Table 1.
Patient number | Sex | Age at onset | Ca mmol/L | iPTH pg/mL | Associated clinical status |
---|---|---|---|---|---|
1 | Male | 12 days | 1.22 | 13.0 | Post colostomy |
2 | Male | 21 days | 1.59 | 7.3 | Post colostomy |
3 | Male | 23 days | 1.16 | 34.9 | Heart failure |
4 | Male | 30 days | 1.19 | 14.7 | Heart failure |
5 | Female | 30 days | 1.49 | <3.0 | Post chemotherapy (Busulfan) |
6 | Male | 13 years | 1.84 | 5.8 | |
7 | Female | 13 days | 1.04 | 10.9 | Pneumonia |
8 | Male | 7 days | 1.12 | 14.0 | Heart failure |
9 | Female | 12 days | 1.15 | 9.4 | Heart failure |
10 | Female | 21 days | 0.94 | 7.3 | Respiratory distress |
11 | Male | 15 years | 1.71 | 36.4 | Post-exercise |
12 | Female | 9 days | 1.55 | 38.9 | Heart failure |
13 | Male | 9 days | 1.65 | 30.7 | Heart failure |
Ca, calcium; iPTH, intact parathyroid hormone.